DPP as A Potential Drug Target (P12105)

Target Name: Dipeptidyl-Peptidase

NCBI ID: P12105

Dipeptidyl-Peptidase

Other Name(s): DPP

DPP as A Potential Drug Target

Dipeptidyl-Peptidase (nonspecified subtype) (DPP) is an enzyme that plays a critical role in the breakdown of proteins into smaller peptides. This process, known as protein degradation, is essential for maintaining the structure and function of proteins, and is a key step in the regulation of protein homeostasis. DPP is a widely expressed protein that is involved in various cellular processes, including cell signaling, inflammation, and metabolism.

DPP has been identified as a potential drug target due to its involvement in several diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. In addition, DPP has also been shown to be a biomarker for several diseases, including cancer and neurodegenerative diseases.

One of the main reasons for the potential of DPP as a drug target is its unique structure and mechanism of action. DPP is a single-chain protein that contains a catalytic active site and a regulatory domain. The catalytic active site is responsible for the conversion of peptides into smaller peptides, while the regulatory domain is responsible for regulating the activity of the enzyme. This unique structure allows DPP to interact with small molecules and other proteins in a specific and efficient manner.

DPP has been shown to play a critical role in several cellular processes, including cell signaling, inflammation, and metabolism. For example, DPP has been shown to be involved in the regulation of cell signaling pathways, including the TGF-β pathway. This pathway plays a key role in the regulation of cell growth, differentiation, and survival, and is often involved in the development and progression of cancer. In addition, DPP has also been shown to be involved in the regulation of inflammation and immune responses.

DPP has also been shown to be involved in the regulation of metabolism and energy homeostasis. For example, DPP has been shown to be involved in the regulation of protein synthesis and degradation, as well as the regulation of lipid metabolism. These processes are essential for maintaining cellular health and are often disrupted in diseases such as cancer and neurodegenerative diseases.

In addition to its role in cellular processes, DPP has also been shown to be a potential biomarker for several diseases, including cancer and neurodegenerative diseases. For example, DPP has been shown to be involved in the regulation of several proteins that are associated with cancer, including the androgen receptor, estrogen receptor, and PIK3CA. In addition, DPP has also been shown to be involved in the regulation of neurodegenerative diseases, including Alzheimer's disease and Parkinson's disease.

The potential of DPP as a drug target is based on several different factors. First, DPP has been shown to play a critical role in the regulation of cellular processes that are often disrupted in diseases, such as cancer and neurodegenerative diseases. Second, DPP has a unique structure and mechanism of action that allows it to interact with small molecules and other proteins in a specific and efficient manner. Finally, DPP has been shown to be involved in several potential drug targets that have been identified and are currently being targeted by the pharmaceutical industry.

In conclusion, Dipeptidyl-Peptidase (nonspecified subtype) (DPP) is an enzyme that plays a critical role in the breakdown of proteins into smaller peptides. This process is essential for maintaining the structure and function of proteins and is a key step in the regulation of protein homeostasis. DPP has been identified as a potential drug target due to its involvement in several diseases, including cancer and neurodegenerative diseases. Further research is needed to fully understand the unique mechanism of action of DPP and to develop effective treatments for these diseases.

Protein Name: Dipeptidyl-Peptidase (nonspecified Subtype)

The "Dipeptidyl-Peptidase Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about Dipeptidyl-Peptidase comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets